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Abstract 26 
Major traumatic injury induces significant remodelling of the circulating neutrophil pool and 27 
loss of bactericidal function. Although a well-described phenomenon, research to date has 28 
only analysed blood samples acquired post-hospital admission, and the mechanisms that 29 
initiate compromised neutrophil function post-injury are therefore poorly understood. Here, 30 
we analysed pre-hospital blood samples acquired from 62 adult trauma patients (mean age 44 31 
years, range 19-95 years) within 1-hour of injury (mean time to sample 39 minutes, range        32 
13-59 minutes). We found an immediate impairment in neutrophil extracellular trap (NET) 33 
generation in response to phorbol 12-myristate 13-acetate (PMA) stimulation, which 34 
persisted into the acute post-injury phase (4-72 hours). Reduced NET generation was 35 
accompanied by reduced reactive oxygen species production, impaired activation of mitogen-36 
activated protein kinases and a reduction in neutrophil glucose uptake and metabolism to 37 
lactate. Pre-treating neutrophils from healthy subjects with mitochondrial-derived damage-38 
associated molecular patterns (mtDAMPs), whose circulating levels were significantly 39 
increased in our trauma patients, reduced NET generation. This mtDAMP-induced 40 
impairment in NET formation was associated with an N-formyl peptide mediated activation 41 
of AMP-activated protein kinase (AMPK), a negative regulator of aerobic glycolysis and 42 
NET formation. Indeed, activation of AMPK via treatment with the AMP-mimetic AICAR 43 
significantly reduced neutrophil lactate production in response to PMA stimulation, a 44 
phenomenon that we also observed for neutrophils pre-treated with mtDAMPs. Furthermore, 45 
the impairment in NET generation induced by mtDAMPs was partially ameliorated by pre-46 
treating neutrophils with the AMPK inhibitor compound C. Taken together, our data 47 
demonstrate an immediate trauma-induced impairment in neutrophil anti-microbial function 48 
and identify mtDAMP release as a potential initiator of acute post-injury neutrophil 49 
dysfunction. 50 
 51 
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Introduction 76 
 77 
Major injury induces significant phenotypic and functional remodelling of the peripheral 78 
neutrophil pool, attributable in part to the emergence into circulation of immature 79 
granulocytes (IGs) and highly mature neutrophil subsets (Hampson et al. 2017; Hazeldine et 80 
al. 2014; Hazeldine et al. 2017; Leliefeld et al. 2016; Pillay et al. 2012). Alongside changes 81 
in the surface expression of adhesion molecules and chemokine receptors (Johansson et al. 82 
2011; Visser et al. 2011; Visser et al. 2012), immediate and prolonged impairments in 83 
phagocytosis (Hampson et al. 2017; Liao et al. 2013), reactive oxygen species (ROS) 84 
production (Hampson et al. 2017; Hazeldine et al. 2017) and chemotaxis (Li et al. 2015; 85 
Tarlowe et al. 2003) have been reported for neutrophils isolated from critically-injured 86 
patients. Whilst understanding of trauma-induced changes in neutrophil intracellular 87 
bactericidal function is well developed, few studies have investigated the impact of injury on 88 
the extracellular defensive mechanisms of neutrophils and how soon after injury, any 89 
compromise occurs. 90 
 91 
Comprised of a DNA backbone decorated with granular and cytosol-derived peptides and 92 
enzymes, neutrophil extracellular traps (NETs) are an extracellular anti-microbial defence 93 
mechanism deployed to prevent pathogen dissemination (Brinkmann and Zychlinsky 2012). 94 
Studies that have examined NET generation post-injury have reported an increase in ex vivo 95 
NET formation by resting neutrophils (Itagaki et al. 2015; Li et al. 2015), a hyperactivity that 96 
may reflect their in vivo exposure to  high mobility group box-1 (HMGB-1) and interleukin 97 
(IL)-33, two NET-inducing alarmins whose circulating concentrations are significantly 98 
increased post-injury (Cohen et al. 2009; Tadie et al. 2013; Xu et al. 2017). However, in 99 
terms of stimulus-induced NET generation, comparable (Itagaki et al. 2015) or reduced 100 
(Hampson et al. 2017; Li et al. 2015) NET production in response to stimulation with 101 
phorbol 12-myristate 13-acetate (PMA) has been reported post- trauma. Of these studies, only 102 
one performed quantitative analysis (Hampson et al. 2017), and neither study that reported a 103 
post-injury reduction in NET formation investigated the mechanism(s) responsible (Hampson 104 
et al. 2017; Li et al. 2015). 105 
 106 
Activation of three non-redundant molecular processes underpin PMA-induced NET 107 
generation. Produced by the multi-subunit enzyme nicotinamide adenine dinucleotide 108 
phosphate (NADPH) oxidase, ROS generation is essential for the process of chromatin 109 
decondensation that precedes NET release (Fuchs et al. 2007; Kirchner et al. 2012). 110 
Occuring prior to (Hakkim et al. 2011) or following (Keshari et al. 2013) ROS production, 111 
activation of the mitogen activated protein kinases p38 and extracellular signal regulated 112 
kinase 1/2 (ERK 1/2), triggers NET formation by inhibiting caspase activation and increasing 113 
expression of the pro-survival protein Mcl-1, thus promoting NET production over the 114 
induction of apoptosis (Hakkim et al. 2011; Keshari et al. 2013). Finally, glycolysis is a 115 
fundamental metabolic requirement for PMA-induced NET formation, with the uptake and 116 
breakdown of extracellular glucose a necessity for the process of DNA expulsion (Rodriguez-117 
Espinosa et al. 2015).  118 
 119 
Trauma-associated tissue damage results in the release into the circulation of damage-120 
associated molecular patterns (DAMPs), a collection of cytosolic, mitochondrial and nuclear-121 
derived proteins and DNA (Cohen et al. 2009; Kaczmarek et al. 2018; Zhang et al. 2010). 122 
Whilst renowned for their role in immune activation (Hazeldine et al. 2015; Zhang et al. 123 
2010), data are emerging that suggests mitochondrial-derived DAMPs (mtDAMPs), which 124 
include N-formylated peptides and mitochondrial DNA (mtDNA), possess immune tolerising 125 
4 
 
properties. For instance, it has been shown in vitro that monocytes pre-exposed to mtDNA 126 
(Fernandez-Ruiz et al. 2014) and neutrophils pre-treated with whole mtDAMP preparations 127 
(Zhang et al. 2010) exhibit impaired cytokine production and calcium mobilisation 128 
respectively upon secondary stimulation. Furthermore, a significant reduction in stimulus-129 
induced ROS production and transmigration was reported for neutrophils pre-exposed to 130 
bacterial-derived or synthetic N-formylated peptides (Gabl et al. 2018; Kaczmarek et al. 131 
2018; Li et al. 2015), both of which signal through the same formyl peptide receptor (FPR) as 132 
mitochondrial-derived formyl peptides. Based on these observations, the concept of 133 
mtDAMP-induced tolerance has been coined and proposed to be a potential mechanistic 134 
explanation for the state of peripheral neutrophil dysfunction that develops in the aftermath of 135 
major trauma (Kaczmarek et al. 2018; Li et al. 2015).  136 
 137 
Here, in a prospective observational study of trauma patients, we have performed for the first 138 
time a quantitative assessment of NET production during the pre-hospital, ultra-early (≤60 139 
minutes) and acute (4-72 hours) post-injury phases, and assessed the impact that major injury 140 
has on the molecular processes and signalling pathways that underpin PMA-induced NET 141 
generation. Furthermore, based on the emerging concept of mtDAMP-induced tolerance, we 142 
have investigated whether pre-exposing neutrophils isolated from healthy subjects to 143 
mtDAMPs in vitro results in altered NET generation upon secondary stimulation with PMA 144 
and the mechanisms involved. 145 
 146 
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Materials and methods 176 
 177 
Study design and setting 178 
 179 
This manuscript presents data acquired from subjects enrolled into the Brain Biomarkers after 180 
Trauma Study, an ongoing prospective longitudinal observational study of adult trauma 181 
patients conducted at a single Major Trauma Centre site in the UK (University Hospitals 182 
Birmingham NHS Foundation Trust, Birmingham). Ethical approval for the study was 183 
granted by the North Wales Research Ethics Committee - West (REC reference: 184 
13/WA/0399, Protocol Number: RG_13-164). 185 
 186 
Patient enrolment began in the pre-hospital setting, where on a 24/7 basis between March 187 
2016 and October 2018, emergency care teams acquired blood samples from adult trauma 188 
patients (≥18 years) with a suspected injury severity score (ISS) ≥8 within 1-hour of injury 189 
(defined as the time of phone call to emergency services). In the pre-hospital setting, blood 190 
samples were not taken from patients who were deemed unlikely to survive transportation to 191 
hospital. Post admission, patients were excluded if they were aged <18 years, if pre-hospital 192 
blood samples had been acquired >1 hour post-injury and if clinical assessments confirmed 193 
either an ISS <8 or a previous diagnosis of neuro-degenerative disease. No patients received 194 
blood products in the pre-hospital setting. 195 
 196 
Capacity and consent 197 
 198 
Due to the nature of injuries sustained, patients were unlikely to provide informed consent for 199 
their participation at the time of study enrolment. Consequently, patient recruitment was 200 
performed under the guidance of the Mental Health Capacity Act 2005 for research in 201 
emergency situations and the Declaration of Helsinki. For patients who lacked capacity, an 202 
agreement for study participation was sought from a legal consultee (family member or 203 
clinician not directly involved in the study), with written consent obtained from the patient 204 
once they regained capacity. In instances where the patient did not regain capacity, data were 205 
retained in accordance with the agreement of the legal consultee. 206 
 207 
Blood sampling 208 
 209 
In the pre-hospital environment, peripheral venous blood samples were acquired during the 210 
intravenous cannulation of patients or by venepuncture. Once taken, blood tubes were stored 211 
at room temperature (RT) until arrival at hospital, where analysis began within 1-hour by a 212 
single laboratory researcher on a 24/7 basis. Additional blood samples were acquired 4-12 213 
and 48-72 hours post-injury. At all three time points, blood samples were collected into BD 214 
Vacutainers
®
 (BD Biosciences, Oxford, UK) containing ethylenediaminetetraacetic acid, z-215 
serum clotting activator or 1/10 volume of 3.2% trisodium citrate. Full blood counts were 216 
performed using a Sysmex XN-1000 haematology analyser (Sysmex UK, Milton Keynes, 217 
UK) that measures a white cell differential and IGs, which are defined as promyelocytes, 218 
myelocytes and metamyelocytes. The analyser uses fluorescence dyes that label intracellular 219 
DNA and RNA, with the intensity of the fluorescence signal directly proportional to the 220 
nucleic acid content of the cell. Due to their higher RNA content, IGs are discriminated from 221 
mature neutrophils via their stronger fluorescence signal. Daily internal quality control 222 
measurements (XN check, Sysmex UK) and monthly external quality control samples 223 
(UKNEQAS, Watford, UK) ensured instrument performance.  224 
 225 
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Sixty-seven adults (mean age 31 years, range 18-80) served as a cohort of healthy controls 226 
(HCs). HCs were volunteers who were not taking any regular medication for a diagnosed 227 
illness and did not have an acute episode of infection prior to the time of sampling. The 228 
recruitment of HCs was carried out in accordance with the ethical approval granted by the 229 
University of Birmingham Research Ethics Committee (Ref: ERN_12-1184) with written 230 
informed consent from all subjects. All subjects gave written informed consent in accordance 231 
with the Declaration of Helsinki. 232 
 233 
Preparation of mtDAMPs and mtDNA 234 
 235 
MtDNA and mtDAMPs were prepared from mitochondria isolated from the K562 tumour 236 
cell line (ATCC
®
, Teddington, Middlesex, UK) as described previously (Hazeldine et al. 237 
2015). MtDNA concentration and protein content within mtDAMPs were determined by 238 
spectrophotometry (Nanodrop 2000; Thermo Fisher Scientific, Paisley, UK) and preparations 239 
stored at -80
o
C prior to use.  240 
 241 
Neutrophil isolation and treatment 242 
 243 
Neutrophils were isolated by Percoll density gradient centrifugation (Scientific Lab Supplies, 244 
Nottingham, UK) with cell purity, which was routinely ≥99%, determined using a Sysmex 245 
XN-1000 haematology analyser. Neutrophils were re-suspended at concentrations of                       246 
1-10x10
6
 /ml in phenol red free or phenol red containing RPMI-1640 media supplemented 247 
with 2 mM L-glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin (GPS; Sigma-248 
Aldrich, Dorset, UK), phenol red free or phenol red containing RPMI-1640 media 249 
supplemented with GPS and 10% heat-inactivated fetal calf serum (HI-FCS; hereafter 250 
referred to as complete medium (CM); Sigma-Aldrich), glucose free RPMI-1640 media 251 
supplemented with GPS (Gibco, Fisher Scientific UK Ltd, Loughborough, UK), Hank’s 252 
balanced salt solution (HBSS) supplemented with calcium and magnesium (hereafter referred 253 
to as HBSS
+/+
; Gibco, Life Technologies, Cheshire, UK) or HEPES buffer containing 1 mM 254 
Ca
2+
.  255 
 256 
For mtDAMPs and mtDNA experiments, neutrophils were pre-treated for 15 minutes 257 
(37
o
C/5% CO2) with 40 or 100 µg/ml mtDAMPs or mtDNA prior to secondary stimulation. 258 
Prior to inclusion in transmigration, lactate and ROS assays, neutrophils were pelleted, 259 
supernatants removed and cells resuspended in specified media. To inhibit FPR-1 signalling, 260 
neutrophils were treated for 60 minutes (37
o
C/5% CO2) with 2.5 µM cyclosporin H (CsH; 261 
Abcam, Cambridge, UK) or vehicle control, prior to mtDAMP stimulation. For compound C 262 
experiments, neutrophils were treated for 60 minutes with 200 µM compound C (Sigma-263 
Aldrich) or vehicle control prior to mtDAMP and PMA treatment. To inhibit calcium-264 
calmodulin-dependent protein kinase kinases (CaMKKs), neutrophils were incubated for 60 265 
minutes (37
o
C/5% CO2) with 2.5 µM STO-609 (Sigma-Aldrich) or vehicle control prior to 266 
mtDAMP treatment. To induce AMP-activated protein kinase (AMPK) signalling, 267 
neutrophils were treated for 60 minutes with 1 mM AICAR (Sigma-Aldrich) prior to PMA 268 
stimulation. 269 
 270 
Ex vivo NET formation 271 
 272 
Neutrophils (2 x 10
5
 in phenol red free or phenol red containing RPMI + GPS or glucose free 273 
RPMI-1640 media supplemented with GPS) were stimulated with 25 nM PMA (Sigma-274 
Aldrich) for 3 hours at 37
o
C/5% CO2. Post-stimulation, supernatants were collected and 275 
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centrifuged at 2,200 x g for 10 minutes at 4
o
C, after which the DNA content of cell-free 276 
supernatants was analysed. Briefly, 100 µl aliquots of cell-free supernatant were incubated 277 
with 1 µM SYTOX Green dye (Life Technologies) for 10 minutes at RT. Fluorescence was 278 
measured using a BioTek Synergy 2 fluorometric plate reader (NorthStar Scientific Ltd, 279 
Sandy, UK) with excitation and emission set at 485 nm and 528 nm respectively. In our 280 
trauma-based studies, DNA quantification was performed using a λ-DNA standard curve 281 
(Fisher Scientific) with PMA-induced NET generation presented as DNA concentration after 282 
subtracting the readings obtained from untreated controls. For mtDAMP experiments, 283 
background fluorescence values acquired from SYTOX Green staining of mtDAMPs in the 284 
absence of neutrophils were subtracted from test readings, with NET production expressed as 285 
a fold increase above untreated controls.  286 
 287 
Visualisation of NETs by fluorescence microscopy 288 
 289 
2 x 10
5 
neutrophils in phenol red free or phenol red containing RPMI + GPS or glucose free 290 
RPMI-1640 media supplemented with GPS were seeded onto glass coverslips and incubated 291 
for 30 minutes at 37
o
C/5% CO2 to allow for cell adherence. Following a 3-hour stimulation 292 
with 25 nM PMA (37
o
C, 5% CO2), samples were fixed for 30 minutes with 4% 293 
paraformaldehyde (37
o
C, 5% CO2), washed three times in phosphate buffered saline (PBS) 294 
and permeabilised with 0.1% Triton X-100 (Sigma-Aldrich). DNA was then stained with                295 
1 µM SYTOX Green dye for 5 minutes, after which slides were washed once in PBS, 296 
mounted in fluoromount medium and visualized using a LEICA DMI 6000 B microscope 297 
(LEICA, Milton Keynes, UK) at x20 or x40 objective.  298 
 299 
ROS production 300 
 301 
For ex vivo analysis of neutrophils isolated from trauma patients, ROS generation was 302 
assessed by lucigenin-amplified chemiluminescence. The effect of mtDAMP pre-treatment 303 
on ROS production was examined using luminol-amplified chemiluminescence. In both 304 
instances, 100 µl aliquots of neutrophils (1x10
6
/ml in HBSS
+/+
) were dispensed into wells of 305 
a 96-well white-bottomed flat plate (BD Biosciences), pre-coated with PBS/2% BSA, that 306 
contained 25 µl of luminol (pH 7.3; final concentration 100 µM; Sigma-Aldrich) or lucigenin 307 
(final concentration 200 µM; Sigma-Aldrich) and 50 µl HBSS
+/+
. Neutrophils were then 308 
stimulated with 25 nM PMA or vehicle control, after which ROS generation was assessed at 309 
1-minute intervals for 180 minutes using a Berthold Centro LB 960 luminometer (Berthold 310 
Technologies, Hertfordshire, UK). Experiments were performed in quadruplicate, with ROS 311 
production measured as relative light units and calculated as area under the curve (AUC). 312 
 313 
Measurement of lactate concentration in cell-free culture supernatants 314 
 315 
Neutrophils (2x10
6
 in phenol red free RPMI + GPS) were stimulated for 1, 2 or 3 hours 316 
(37
0
C, 5% CO2) with 25 nM PMA or vehicle control. At each time-point, cell-free 317 
supernatants were harvested (800 x g, 5 mins, 4
0
C) and samples stored at -80
0
C prior to 318 
analysis. Lactate concentration in 25 µl aliquots of supernatant was determined using a 319 
commercially available lactate assay kit according to manufacturer’s instructions (Sigma-320 
Aldrich).   321 
 322 
 323 
 324 
 325 
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Glucose uptake assay 326 
 327 
Following a 15-minute rest period at 37
o
C/5% CO2, neutrophils (1x10
6 
in RPMI-1640 media 328 
without glucose) were stimulated for 60 minutes (37
o
C/5% CO2) with 25 nM PMA or 329 
vehicle. With 10 minutes of the stimulation period remaining, the fluorescent glucose 330 
analogue 2-N-7-nitrobenzen-2oxa-1,3-diazol-4-yl amino-2-deoxyglucose (2-NBDG; Thermo 331 
Fisher) at a final concentration of 100 µM was added. Post-incubation, samples were washed 332 
and cells re-suspended in glucose free RPMI in preparation for flow cytometric analysis, 333 
which was performed on a CyAnADP
TM
 bench top cytometer (Dako, Cambridgeshire, UK). 334 
10,000 neutrophils were collected and FL1 mean fluorescence intensity values recorded.  335 
 336 
Neutrophil transmigration 337 
 338 
Neutrophils (1x10
7
/ml) in HEPES buffer containing 1 mM Ca
2+
 were incubated for 30 339 
minutes in a 37
0
C water bath with 3 µg/ml calcein-acetoxmethyl ester (calcein-AM, Fisher 340 
Scientific), after which cells were pelleted, supernatants removed and neutrophils re-341 
suspended at 1x10
7
/ml in phenol red free CM. A total of 1x10
6
 neutrophils were dispensed 342 
into the upper chambers of polycarbonate membrane cell culture inserts with 3 µM pores 343 
(Corning, New York, USA) that had been pre-loaded into wells of a 24-well flat bottomed 344 
plate (BD Biosciences) containing pre-warmed phenol red free CM and 1 nM LTB4 (R and D 345 
Systems, Abingdon, UK). Following a 90-minute incubation at 37
0
C, cell culture inserts were 346 
removed and plates read immediately for calcein fluorescence using a BioTek Synergy 2 347 
fluorometric plate reader with excitation and emission set at 485 nm and 528 nm respectively. 348 
Fluorescence intensities were converted into neutrophil numbers via the use of a standard 349 
curve that was generated from calcein-AM loaded neutrophils that had been incubated 350 
alongside the test samples in the conditions described above. The number of neutrophils 351 
measured in media in which no chemokine was added was subtracted from the numbers 352 
calculated for wells that contained 1 ng/ml LTB4 in order to determine specific chemokine-353 
mediated migration. 354 
 355 
Assessment of neutrophil phenotype  356 
 357 
Freshly isolated neutrophils (1x10
5 
in CM)
 
were stimulated with 100 µg/ml mtDAMPs or 358 
vehicle control for 15 minutes at 37
o
C in a humidified 5% CO2 atmosphere. Post–treatment, 359 
samples were stained on ice for 20 minutes with the following mouse anti-human monoclonal 360 
antibodies or their concentration-matched isotype controls: 2 µg/ml fluorescein 361 
isothiocyanate (FITC)-labelled CD62L (clone DREG56; eBioscience, Hatfield, UK); 1 µg/ml 362 
CXCR1-FITC (clone eBIO8F1-1-4; eBioscience); 0.5 µg/ml R-phycoerythrin (PE)-labelled 363 
CXCR2-PE (clone eBio5E8-C7-F10; eBioscience) or 2.5 µg/ml allophycocyanin (APC)-364 
labelled CD11b (clone ICRF44, BioLegend, London, UK). Post incubation, cells were 365 
pelleted (250 x g, 5 minutes, 4
0
C), supernatants discarded and neutrophils washed once in 366 
PBS/1%BSA. Following resuspension in PBS, samples were transferred to polypropylene 367 
FACS tubes for flow cytometric analysis, which was performed on an AccuriC6
TM
 bench top 368 
cytometer (BD Biosciences). 10,000 neutrophils, gated according to their forward scatter 369 
(FS)/sideward scatter (SS) properties, were acquired for analysis, where receptor expression 370 
was measured as median fluorescence intensity (MedFI).  371 
 372 
 373 
 374 
 375 
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Cell signalling measurements  376 
 377 
To determine signalling through AMPK and MAPK pathways, cell lysates prepared from 378 
2x10
6 
resting neutrophils, 1x10
6 
neutrophils stimulated with either 25 nM PMA or 100 µg/ml 379 
mtDAMPs for 2-90 minutes (37
o
C/5% CO2), or 2x10
6 
neutrophils stimulated with 100 µg/ml 380 
mtDAMPs for 5 minutes following 1-hour pre-treatment with 2.5 µM STO-609 or 2.5 µM 381 
CsH were separated on 10 or 12% SDS-polyacrylamide gels. Following protein transfer to 382 
polyvinylidene difluoride membranes (Bio-Rad, Hertfordshire, UK), blots were probed 383 
overnight at 4
o
C with rabbit anti-human antibodies (Cell Signalling Technology, 384 
Massachusetts, USA) directed against phosphorylated AMPK (pAMPK), phosphorylated 385 
ERK1/2 (pERK1/2), phosphorylated P38 (pP38), lactate dehydrogenase A (LDHA) or 386 
pyruvate kinase (PKM2). Post incubation, membranes were washed in tris-buffered saline 387 
containing 0.001% tween (TBST) and incubated for 1 hour at RT with a goat anti-rabbit 388 
secondary antibody conjugated to horse radish peroxidase (HRP; diluted 1:4000 in TBST; GE 389 
Healthcare, Buckinghamshire, UK). HRP activity was detected using enhanced 390 
chemiluminescence (Bio-Rad). To confirm equal loading of proteins, blots were probed with 391 
antibodies against total ERK 1/2, total P38 (1:1000; Cell Signalling Technology) or β-actin 392 
(1:5000, GeneTex, California, USA). Densitometry analysis was performed using Image J 393 
software (National Institutes of Health, Bethesda, MD, USA). 394 
 395 
Enzyme-linked immunosorbent assays (ELISAs) 396 
 397 
Serum was prepared from blood collected into BD vacutainers containing z-serum clotting 398 
activator. Following a 30-minute incubation at RT, blood samples were centrifuged at 1,620 x 399 
g for 10 minutes at 4
0
C, after which serum was aliquoted and stored at -80
0
C until analysed. 400 
ELISAs to measure serum concentrations of HMGB-1 (IBL International, Hamburg, 401 
Germany), mitochondrial encoded NADH dehydrogenase 6 (ND6; MyBioSource, San Diego, 402 
California, USA) and IL-33 (R and D Systems) were performed in accordance with 403 
manufacturer’s instructions.  404 
 405 
Statistical analyses 406 
 407 
Statistical analyses were performed using GraphPad Prism
®
 software (GraphPad Software 408 
Ltd, California, USA). Data distribution was examined using the Kolmogorov-Smirnov or 409 
Shapiro-Wilk normality test. For data that followed a normal distribution, paired student T-410 
tests, a repeated measures ANOVA with Bonferroni multiple comparison post hoc test or a 411 
one way ANOVA with Dunnett’s multiple comparison post hoc test were performed. For 412 
non-normally distributed data, a Wilcoxon matched-pairs signed rank test, a Friedman test 413 
with Dunn’s multiple comparison post hoc test or a Kruskal-Wallis with Dunn’s multiple 414 
comparison post hoc test was performed. For box and whisker plots, whiskers represent 415 
minimum and maximum values. Statistical significance was accepted at p≤0.05. 416 
 417 
 418 
 419 
 420 
 421 
 422 
 423 
 424 
 425 
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Results  426 
 427 
Patient enrolment and demographics 428 
 429 
1,070 adult trauma patients were screened for study inclusion, with 87 subjects enrolled into 430 
the study (Supplementary Figure 1). Of these, 62 patients with a mean age of 44 years (range 431 
19-95 years) and mean injury severity score of 26 (range 9-57) had their immune function 432 
analysed (Table 1). The mean time of pre-hospital blood sampling was 39 minutes post-injury 433 
(range 13-59 minutes).  434 
 435 
PMA-induced NET production is impaired post-trauma 436 
 437 
Compared to neutrophils isolated from HCs, neutrophils acquired from trauma patients within 438 
1-hour of injury exhibited significantly enhanced basal NET generation (Figure 1A), a 439 
hyperactivity that was accompanied by significantly elevated serum concentrations of 440 
HMGB-1 (Figure 1B) and IL-33 (Figure 1C). By the 4-12 and 48-72 hour post-injury time 441 
points, a significant reduction in basal NET production was observed (Figure 1A). In 442 
response to stimulation with PMA, patient neutrophils released significantly less DNA at all 443 
three sampling time-points when compared to HCs (Figure 1D). Fluorescence microscopy 444 
confirmed the impairment in NET generation (Figure 1E). 445 
 446 
ROS production in response to PMA stimulation is reduced in the acute post-injury 447 
phase 448 
 449 
ROS generation is a non-redundant event in NET formation (Fuchs et al. 2007). Having 450 
observed trauma-induced alterations in both basal and stimulated NET formation, we 451 
examined the effect of injury on ROS production. In the absence of stimulation, patient 452 
neutrophils isolated 48-72 hours post-injury exhibited significantly enhanced ROS production 453 
when compared to the response of neutrophils from HCs (Figure 2A). No difference in basal 454 
ROS generation was seen between HCs and patient neutrophils acquired ≤1-hour or 4-12 455 
hours post-injury (Figure 2A). In response to PMA stimulation, there was a significant 456 
reduction in ROS production, relative to HCs, for neutrophils isolated from patients only at 457 
the 48-72 hour post-injury time point (Figure 2B).  458 
 459 
Traumatic injury results in an immediate and sustained elevation in the frequency and 460 
absolute number of circulating IGs 461 
 462 
Compared to their mature counterparts, immature neutrophils exhibit impaired ex vivo NET 463 
production and reduced ROS production upon stimulation with inflammatory agonists 464 
(Hampson et al. 2017; Martinelli et al. 2004). Relative to the values recorded for HCs, 465 
trauma patients presented, at all sampling time points, with a significantly elevated frequency 466 
(Figure 2C) and absolute number (Figure 2D) of circulating IGs.   467 
 468 
Traumatic injury is associated with impaired MAPK signalling 469 
 470 
MAPK signalling is a prerequisite for PMA-induced NET production (Keshari et al. 2013). 471 
Due to the significant lymphocytosis that occurs within minutes of traumatic injury 472 
(Hazeldine et al. 2017), and the small blood volume collected from patients at the scene of 473 
injury, we were unable to isolate a sufficient number of neutrophils from pre-hospital blood 474 
samples to examine MAPK signalling. However, we found neutrophils isolated from patients 475 
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4-12 and 48-72 hours post-injury exhibited significantly increased phosphorylation of P38 476 
MAPK (Figure 3A) but not ERK1/2 (Figure 4A) in the absence of exogenous stimulation.  477 
 478 
In response to treatment with PMA, neutrophils obtained from HCs exhibited a significant 479 
increase in P38 phosphorylation (Figure 3B-D). In contrast, no significant PMA-induced 480 
increase in P38 phosphorylation was observed for neutrophils isolated from trauma patients  481 
4-12 or 48-72 hours post-injury (Figures 3B-D). Compared to untreated cells, neutrophils 482 
isolated from HCs and trauma patients at the 4-12 and 48-72 hour post-injury time points  483 
displayed a significant increase in ERK1/2 phosphorylation following 5, 10 and 15 minutes 484 
of PMA stimulation (Figure 4B-D). However, across these three stimulation time points, the 485 
degree of ERK1/2 phosphorylation was significantly greater in neutrophils isolated from HCs 486 
(Figure 4B-D) 487 
 488 
Altered neutrophil glucose uptake and metabolism post-trauma  489 
 490 
Confirming the results of a recent study that demonstrated a necessity for exogenous glucose 491 
in PMA-induced NET production (Rodriguez-Espinosa et al. 2015), we found neutrophils 492 
cultured in glucose free media released significantly less DNA upon PMA stimulation than 493 
neutrophils stimulated in glucose containing media (Supplementary Figure 2). Based on our 494 
observation of a trauma-induced impairment in ex vivo NET generation following PMA 495 
treatment, we investigated the effect of injury on neutrophil glucose uptake. Using the 496 
fluorescent glucose analogue 2-NBDG, enhanced basal glucose uptake was recorded for 497 
neutrophils isolated from trauma patients within 1-hour of injury (Figure 5A), but in response 498 
to PMA stimulation, a significant trauma-induced impairment in neutrophil glucose uptake 499 
was seen at all sampling time points (Figure 5B).  500 
 501 
We next examined whether injury impacted upon glucose metabolism, a non-redundant step 502 
in NET formation triggered by PMA stimulation (Rodriguez-Espinosa et al. 2015). Using 503 
lactate production as a marker of neutrophil glycolytic activity, we measured lactate 504 
concentrations in supernatants collected from resting and PMA-stimulated neutrophils 505 
following a 3-hour in vitro culture. Compared to HCs, neutrophils isolated from trauma 506 
patients at the 48-72 hour post-injury time-point exhibited enhanced basal (Figure 5C) but 507 
impaired PMA-induced lactate production (Figure 5D). The increase in basal lactate 508 
generation was accompanied by a significant up-regulation in the expression of the glycolytic 509 
enzymes pyruvate kinase and lactate dehydrogenase A (Figure 5E-F).  510 
 511 
Neutrophils pre-treated with mtDAMPs exhibit impaired NET production but 512 
enhanced ROS generation upon secondary stimulation   513 
 514 
Compared to the levels measured in samples from HCs, serum concentrations of the 515 
mitochondrial-derived protein ND6 were significantly increased in patients at all post-injury 516 
time points, confirming the release of mtDAMPs after trauma (Figure 6A). Demonstrating the 517 
immune stimulatory properties of mtDAMPs, we measured significantly reduced CD62L, 518 
CXCR1 and CXCR2 expression as well as increased CD11b density on the surface of 519 
mtDAMP treated neutrophils (Supplementary Table 1). These changes in neutrophil surface 520 
phenotype were accompanied by activation of ERK 1/2 MAPK signalling (Supplementary 521 
Figure 3A). The emerging concept of mtDAMP-induced tolerance of neutrophil function is 522 
based in part on experimental data that has shown prior activation of neutrophils with 523 
bacterial-derived N-formylated peptides results in impaired migration upon secondary 524 
stimulation (Li et al. 2015). Confirming these findings, we found that neutrophils pre-treated 525 
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with 40 or 100 µg/ml preparations of whole mtDAMPs exhibited significantly reduced 526 
transmigration towards the chemokine LTB4 (Supplementary Figure 3B). In contrast, no 527 
impairment in migration was witnessed for neutrophils pre-treated with 100 µg/ml of purified 528 
mtDNA (Supplementary Figure 3C).  529 
 530 
To determine whether prior mtDAMP treatment influenced PMA-induced NET production, 531 
fluorometric analysis was performed on cell-free supernatants collected from cultures of 532 
PMA stimulated neutrophils that had been pre-treated with mtDAMPs or vehicle control. 533 
Analysis revealed neutrophils pre-exposed to 40 or 100 µg/ml mtDAMPs released 534 
significantly less DNA following a 3-hour stimulation with PMA than vehicle-treated 535 
controls (Figure 6B). Fluorescence microscopy confirmed this mtDAMP-induced inhibition 536 
of PMA-induced NET generation (Figure 6C). Interestingly, focussing upon neutrophils pre-537 
treated with 100 µg/ml mtDAMPs, images revealed that despite a significant reduction in 538 
NET formation, the cells had lost their multi-lobed nuclear morphology following stimulation 539 
with PMA, presenting with decondensed nuclear material (Figure 6C). In contrast to whole 540 
mtDAMP preparations, neutrophils pre-treated with 40 µg/ml of purified mtDNA prior to 541 
PMA stimulation showed no impairment in NET production (data not shown). Interestingly, 542 
ROS production, which is a prerequisite for NET formation, was significantly higher upon 543 
secondary PMA stimulation for neutrophils pre-treated with 100 µg/ml mtDAMPs                  544 
(Figure 6D).  545 
 546 
AMPK is activated by mtDAMP treatment and inhibition of AMPK partially 547 
ameliorates the mtDAMP-induced reduction in NET formation  548 
 549 
In stimulated T cells, elevated intracellular calcium levels activate AMPK, a recently 550 
described negative regulator of PMA-induced NET formation (Tamas et al. 2006; Wang et 551 
al. 2015). As raised intracellular calcium levels are a feature of mtDAMP treated neutrophils 552 
(Zhang et al. 2010), we determined the activation status of AMPK in neutrophils following 553 
mtDAMP stimulation. To do this, cell lysates, prepared from neutrophils stimulated for 2, 5, 554 
10 and 15 minutes with 100 µg/ml mtDAMPs, were probed with a phospho-specific antibody 555 
directed against Thr172, a residue within the activation loop of AMPK. As shown in Figure 556 
7A, mtDAMP treatment resulted in an immediate and persistent phosphorylation of residue 557 
Thr172. Treating neutrophils with the FPR-1 antagonist CsH prior to mtDAMP stimulation 558 
resulted in a significant reduction in AMPK phosphorylation, suggesting that N-formyl 559 
peptides drive mtDAMP-induced activation of AMPK (Figure 7B). In antigen challenged T 560 
cells, phosphorylation of AMPK requires the activation of calcium-calmodulin-dependent 561 
protein kinase kinases (CaMKKs), a class of serine/threonine protein kinases activated by 562 
increases in intracellular calcium (Tamas et al. 2006). To investigate whether CaMKKs were 563 
involved in mtDAMP-induced phosphorylation of AMPK in neutrophils, we treated 564 
neutrophils with the CaMKK selective inhibitor STO-609 prior to mtDAMP stimulation. 565 
Compared to vehicle control, a significant impairment in mtDAMP-induced activation of 566 
AMPK was detected in neutrophils pre-treated with STO-609 (Figure 7C). 567 
 568 
AMPK has recently been shown to be a negative regulator of PMA-induced NET formation 569 
(Jiang et al. 2014; Wang et al. 2015). To investigate whether AMPK signalling was involved 570 
in mtDAMP-mediated suppression of NET formation, we treated neutrophils with compound 571 
C, an inhibitor of AMPK, prior to mtDAMP exposure. Compared to vehicle control, 572 
significantly greater NET production in response to PMA stimulation was recorded for 573 
neutrophils pre-treated with compound C (Figure 7D).  574 
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MtDAMP pre-treatment results in impaired lactate generation by neutrophils upon 575 
secondary stimulation with PMA 576 
 577 
Confirming results of previous studies that had shown AMPK to be a negative regulator of 578 
aerobic glycolysis (Faubert et al. 2013), we measured significantly lower concentrations of 579 
lactate in supernatants collected from PMA stimulated neutrophils that had been pre-treated 580 
with the AMP mimetic AICAR when compared to vehicle control (Figure 8A). Given that 581 
aerobic glycolysis is a key metabolic event in PMA-induced NET formation (Rodriguez-582 
Espinosa et al. 2015) and our observiation of reduced NET generation following PMA 583 
stimulation for neutrophils pre-treated with mtDAMPs (Figure 6B-C), we investigated 584 
whether AMPK activation triggered by mtDAMP exposure was associated with an 585 
impairment in neutrophil glycolysis. Following 1, 2 or 3 hour stimulation with PMA, 586 
significantly lower lactate concentrations were measured in supernatants collected from 587 
neutrophils pre-treated with 100 µg/ml mtDAMPs (Figure 8B).  588 
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Discussion 625 
 626 
Here, via the analysis of blood samples acquired from trauma patients within 1-hour of 627 
injury, we have shown for the first time that major trauma results in an immediate impairment 628 
in neutrophil anti-microbial defences, specifically the formation of NETs. This defect 629 
persisted into the acute post-injury phase (4-72 hours) and was accompanied by impaired 630 
ROS production, MAPK activation and a reduction in both glucose uptake and breakdown. 631 
Furthermore, we showed that the trauma-induced reduction in NET formation could be 632 
replicated in vitro by treating neutrophils isolated from healthy donors with mtDAMPs prior 633 
to secondary stimulation. Thus, our data provides support for the emerging concept of 634 
mtDAMP-induced tolerance, where the post-injury release of mtDAMPs into the circulation 635 
has been proposed to contribute to the neutrophil dysfunction that develops in the aftermath 636 
of traumatic injury (Kaczmarek et al. 2018; Li et al. 2015). 637 
 638 
In the absence of secondary stimulation, neutrophils obtained from patients within minutes, 639 
but not hours, of injury released significantly more DNA into culture supernatants than 640 
neutrophils isolated from healthy controls. This immediate trauma-induced increase in basal 641 
NET generation is in agreement with the findings of our previous trauma-based study, where 642 
in pre-hospital plasma samples, we reported the presence of citrullinated histone H3, a 643 
protein that decorates the nuclear DNA backbone of NETs (Hazeldine et al. 2017; Liu et al. 644 
2012). Thus, taken together, our results suggest that neutrophils are immediately exposed to 645 
NET-inducing stimuli post-injury. Supporting this proposal, data presented here and in our 646 
previous manuscript have shown serum concentrations of known NET inducers, which 647 
include TNF-α, IL-8, IL-33 and HMGB-1 are all significantly elevated within minutes of 648 
injury (Hazeldine et al. 2017; Keshari et al. 2012; Liu et al. 2012; Tadie et al. 2013; Yazdani 649 
et al. 2017). Of these agonists, the immediate release of HMGB-1 may be particularly 650 
pertinent given that within 60 minutes of in vitro co-culture, neutrophils stimulated with this 651 
nuclear-derived DAMP have been shown to generate NETs (Huang et al. 2015). Moreover, 652 
as HMGB-1 induced NET formation is independent of ROS generation by NADPH oxidase 653 
(Tadie et al. 2013), immediate exposure to this DAMP could explain our observation of 654 
enhanced ex vivo NET formation by neutrophils isolated from pre-hospital blood samples that 655 
exhibited no difference in basal ROS production when compared to neutrophils from HCs. In 656 
terms of stimulus-induced NET formation, this is the first study to show quantitatively that 657 
trauma results in reduced NET generation to PMA stimulation. We confirmed this 658 
impairment, which was evident at all three sampling time points, by fluorescent microscopy, 659 
with our images akin to those presented in a previous study that reported a qualitative post-660 
injury reduction in PMA-induced NET production in a much smaller cohort of trauma 661 
patients (Li et al 2015).  662 
 663 
The processes that mediate PMA-induced NET generation are well defined, with prominent 664 
roles assigned to ROS generation, MAPK activation, glucose uptake and glycolysis (Fuchs et 665 
al. 2007; Hakkim et al. 2011; Keshari et al. 2013; Rodriguez-Espinosa et al. 2015). Across 666 
our sampling time points, we observed defects in each of these processes, suggesting that 667 
multiple impairments rather than a single aberration underlie the post-injury reduction in 668 
NET formation. Whilst our data demonstrating a trauma-induced impairment in neutrophil 669 
ROS production has been described previously (Hampson et al. 2017; Hazeldine et al. 2017), 670 
we are the first to report a post-trauma reduction in MAPK activation, glucose uptake and 671 
metabolism by neutrophils in response to ex vivo stimulation. Aside from NET production, 672 
other anti-microbial mechanisms of neutrophils utilise glucose. For instance, chemotaxis 673 
requires the uptake of exogenous glucose (Weisdorf et al. 1982), whilst breakdown of 674 
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endogenous glucose is important for stimulus-induced ROS production and phagocytosis 675 
(Rodriguez-Espinosa et al. 2015; Weisdorf et al. 1982). Interestingly, as reported here for 676 
NET generation, these three defence strategies have all been shown in ex vivo assays to be 677 
significantly impaired following trauma (Hampson et al. 2017; Li et al. 2015; Liao et al. 678 
2013; Tarlowe et al. 2003). Thus, the injury-induced reduction we have demonstrated in 679 
glucose uptake and metabolism may be a mechanism underlying many facets of post-trauma 680 
neutrophil dysfunction. Aside from the changes we found in neutrophil signalling and 681 
metabolism, trauma patients presented at all three time points with elevated circulating levels 682 
of IGs. Shown in vitro to exhibit impaired NET production upon secondary stimulation 683 
(Martinelli et al. 2004), the immediate and persistent presence of immature cells offers 684 
another potential mechanistic explanation for the trauma-induced reduction in NET 685 
formation.  686 
 687 
Suggesting that traumatic injury modulates cell metabolism, we demonstrated a post-trauma 688 
elevation in lactate production by resting neutrophils, an observation that is in agreement with 689 
the findings of a previous study. In a cohort of polytrauma patients, Oehler et al reported a 690 
higher glycolytic activity, relative to HCs, for neutrophils isolated from subjects between 48 691 
and 120 hours post-injury, an enhancement they attributed to increased expression and 692 
activity of pyruvate kinase, a glycolytic enzyme that catalyses the conversion of 693 
phosphoenolpyruvate to pyruvate (Oehler et al. 2000). Here, we confirmed that traumatic 694 
injury induces increased expression of pyruvate kinase and showed that this is accompanied 695 
by increased expression of lactate dehydrogenase A. Whilst up-regulation of lactate 696 
dehydrogenase A, which converts pyruvate to lactate, has been described in transcriptomic 697 
analysis of whole blood leukocytes isolated from critically-ill patients (Nalos et al. 2016), 698 
this is the first study to demonstrate increased protein expression of lactate dehydrogenase in 699 
neutrophils post-injury.  700 
 701 
Accompanying the impairment we observed in ex vivo NET formation was a significant 702 
trauma-induced elevation in the circulating levels of the mitochondrial-derived N-formylated 703 
peptide ND6.  In a recent study, suppressed chemotactic responses towards CXCL1 and 704 
LTB4 were reported for neutrophils pre-treated with synthetic ND6 (Kaczmarek et al. 2018), 705 
a finding that mirrored results of previous studies where prior exposure to bacterial-derived 706 
N-formylated peptides or ND6 respectively was shown to reduce neutrophil migration and 707 
ROS production upon secondary stimulation (Gabl et al. 2018; Li et al. 2015). Adding to this 708 
growing body of literature that suggests a tolerising effect for mitochondrial-derived peptides 709 
on neutrophil function, we demonstrated that neutrophils pre-treated with whole mtDAMP 710 
preparations, but not purified mtDNA, exhibited significantly reduced NET production 711 
following PMA stimulation.  712 
 713 
A striking observation of our NET based assays was that despite an absence of NET 714 
production, mtDAMP pre-treated neutrophils lost their distinctive multi-lobed nuclear 715 
morphology upon PMA challenge. Interestingly, chromatin decondensation in the absence of 716 
DNA release was recently reported for PMA stimulated neutrophils pre-treated with the 717 
glycolysis inhibitor 2-deoxy-glucose (Rodriguez-Espinosa et al. 2015). Using lactate as a 718 
readout of glycolytic activity, we measured significantly reduced lactate concentrations in the 719 
supernatants of mtDAMP pre-treated neutrophils stimulated with PMA, demonstrating that 720 
exposure to mtDAMPs influences the metabolism of immune cells.  721 
 722 
We found that exposing neutrophils to mtDAMPs resulted in activation of the 723 
serine/threonine protein kinase AMPK. In T cells, increases in intracellular calcium levels 724 
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promote AMPK phosphorylation through activation of CaMKKs (Tamas et al. 2006). Our 725 
data demonstrating a significant reduction in mtDAMP-induced phosphorylation of AMPK in 726 
neutrophils pre-treated with the selective CAMMK inhibitor STO-506 indicates this 727 
signalling pathway is also activated in stimulated neutrophils. As the only component of 728 
mtDAMPs that promotes calcium mobilisation in neutrophils (Zhang et al. 2010), signals 729 
derived from N-formyl peptides are likely to have driven the mtDAMP-induced 730 
phosphorylation of AMPK. Supporting this idea, we observed significantly reduced 731 
mtDAMP-induced AMPK phosphorylation in neutrophils pre-treated with CsH, an FPR-1 732 
antagonist that prevents calcium mobilisation upon mtDAMP stimulation (Zhang et al. 2010).  733 
 734 
Demonstrating that AMPK is a negative regulator of NET formation, significantly enhanced 735 
and impaired NET formation has been reported for PMA stimulated neutrophils pre-treated 736 
with AMPK inhibitors and activators respectively (Jiang et al. 2014; Wang et al. 2015). 737 
Supporting these data, we showed significantly greater PMA-induced NET production by 738 
neutrophils treated with the AMPK inhibitor compound C prior to mtDAMP exposure.   How 739 
activation of AMPK inhibits NET formation is currently unknown. Based on published 740 
literature, we propose two mechanisms, both of which revolve around the ability of AMPK to 741 
inhibit the serine/threonine protein kinase mammalian target of rapamycin (mTOR) (Faubert 742 
et al. 2013; MacIver et al. 2011). Firstly, inhibition of mTOR has been shown to significantly 743 
reduce Glut1 transporter activity (Wieman et al. 2007). Given the importance of extracellular-744 
derived glucose in NET formation (Rodriguez-Espinosa et al. 2015), reduced glucose uptake, 745 
secondary to impaired mTOR and Glut1 activity, could contribute to the reduction in NET 746 
production and lactate generation that we observed for neutrophils pre-treated with 747 
mtDAMPs. Furthermore, this mechanism could contribute to the mtDAMP-induced 748 
impairment we reported in neutrophil transmigration since chemotaxis also utilises 749 
extracellular sources of glucose (Weisdorf et al. 1982). Alongside Glut1, mTOR signalling 750 
has been implicated in regulating the expression/activity of hypoxia-inducible factor-1α 751 
(HIF-1α) (Faubert et al. 2013). A transcription factor involved in promoting aerobic 752 
glycolysis, activation of HIF-1α precedes both NET formation (McInturff et al. 2012) and 753 
myeloid cell migration (Cramer et al. 2003). Thus, reduced activity/expression of HIF-1α, 754 
secondary to AMPK-mediated inhibition of mTOR, could be an additional/alternative 755 
explanation for the mtDAMP-induced reduction in lactate generation, NET generation and 756 
neutrophil chemotaxis. Importantly, both these proposed mechanisms could occur in 757 
neutrophils without affecting their capacity for ROS production, which we found was 758 
significantly increased following mtDAMP treatment. Indeed, as the energy required for ROS 759 
generation is derived from endogenous sources of glucose (Rodriguez-Espinosa et al. 2015), 760 
this anti-microbial function could occur in the background of an AMPK driven reduction in 761 
extracellular glucose uptake. Our finding of increased ROS production to PMA stimulation 762 
for neutrophils pre-treated with mtDAMPs contradicts the post-injury impairment we 763 
reported in ROS generation for trauma patients that presented with significantly elevated 764 
serum concentrations of mtDAMPs. We believe this discrepancy may be attributable to 765 
trauma-induced changes in the composition of the circulating neutrophil pool. For example, 766 
traumatic injury results in the emergence into circulation of IGs and CD16
BRIGHT
 CD62L
DIM
 767 
neutrophils, both of which exhibit impaired stimulus-induced ROS generation (Drifte et al. 768 
2013; Sauce et al. 2017). In contrast, healthy subjects, who served as the cohort for our 769 
mtDAMP pre-treatment experiments, possess a homogenous pool of fully-functional mature 770 
neutrophils that would exhibit a greater capacity to respond to stimulation. 771 
 772 
Although we have shown that neutrophils pre-treated with compound C exhibit increased 773 
NET generation upon PMA stimulation, inhibition of AMPK only partially ameliorated the 774 
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reduction in NET formation that occurred with mtDAMP treatment. Other factors aside from 775 
AMPK activation must therefore be involved in mediating the mtDAMP-induced suppression 776 
of NET production. Recently, through a proposed mechanism of action that involved the 777 
prevention of membrane rupture, lactoferrin, an iron-binding glycoprotein stored within the 778 
secondary granules of neutrophils, was found to suppress NET release triggered by PMA 779 
stimulation (Okubo et al. 2016). Indicative of a defect in the latter stages of NET production, 780 
we showed chromatin decondensation in the absence of DNA release was a feature of 781 
mtDAMP-treated neutrophils. Thus, based on this observation and the fact that exposure to 782 
mtDAMPs promotes neutrophil degranulation (Hauser et al. 2010; Hazeldine et al. 2015; 783 
Zhang et al. 2010), we suggest that a mtDAMP-induced release of lactoferrin could represent 784 
an additional mechanistic explanation for the impairment in NET formation that occurs 785 
following mtDAMP exposure.  786 
 787 
This study has some limitations. Conducted at a single major trauma centre, the results of our 788 
prospective observational study are based on the analysis of a small number of patient 789 
samples, meaning our findings require validation in larger independent cohorts. This point is 790 
particularly pertinent to our analysis of pre-hospital blood samples, where inter-individual 791 
variability in immune cell number and volume of blood collected at the scene of injury meant 792 
we were unable to perform all assays on each patient at this time point. As a heterogeneous 793 
collection of proteins, lipids and DNA, no study to date has quantified the exact concentration 794 
of mtDAMPs released into the circulation post-injury. Thus, our in vitro treatment of 795 
neutrophils with 40 or 100 µg/ml mtDAMPs may not be physiologically relevant. However, 796 
these doses match those used in previous in vitro based studies that have examined the effect 797 
of mtDAMP exposure on neutrophil anti-microbial function (Hauser et al. 2010; Hazeldine 798 
et al. 2015; Zhang et al. 2010). Similarly, our decision to use the phorbol ester PMA as an 799 
agonist may be considered a study limitation. However, as a potent stimulus, it allowed us to 800 
study maximal neutrophil responses. Moreover, as the agonist of choice for all previous 801 
trauma-based studies that had examined stimulus-induced NET production post-injury 802 
(Hampson et al. 2017; Itagaki et al. 2015; Li et al. 2015), our use of PMA enabled us to 803 
compare our observations to those in the published literature. 804 
   805 
In summary, this is the first study to describe a quantitative post-trauma reduction in NET 806 
formation as an immediate on-scene phenomenon, which is accompanied by aberrant 807 
intracellular signalling and cell metabolism. In addition, we have shown that the post-injury 808 
reduction in NET generation can be recreated in vitro by treating neutrophils isolated from 809 
healthy subjects with mtDAMPs prior to PMA stimulation. Thus, our data support the 810 
suggestion that the release of mtDAMPs from damaged tissue is a contributory factor in the 811 
reduction in neutrophil function that occurs post-injury (Hampson et al. 2017; Hazeldine et 812 
al. 2017; Li et al. 2015; Liao et al. 2013; Tarlowe et al. 2003). 813 
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Figure legends 1036 
 1037 
Figure 1. Effect of traumatic injury on PMA-induced NET formation. (A) Basal NET 1038 
generation by resting neutrophils isolated from healthy controls (HC) and trauma patients as 1039 
assessed by DNA concentration in cell free supernatants following a 3-hour in vitro culture. 1040 
(B) HMGB-1 and (C) IL-33 concentrations in serum samples from HC and trauma patients. 1041 
IL-33 levels were undetectable (N.D) in serum samples from HC. (D-E) Following a 3-hour 1042 
in vitro stimulation with PMA, NET production by neutrophils from HC and trauma patients 1043 
was compared by measuring DNA concentration in cell free supernatants (D) and 1044 
fluorescence microscopy (E). For supernatant analysis, number of samples are shown below 1045 
each time-point. For microscope images, HC (n=12), ≤1H (n=6),   4-12H (n=6) and 48-72H 1046 
(n=8).  
*
p<0.01, 
**
p<0.001, 
***
p<0.0001 vs. HC. 1047 
 1048 
Figure 2. Neutrophil ROS production and immature granulocyte count post-injury. 1049 
Comparison of basal (A) and PMA-induced (B) ROS production by neutrophils isolated from 1050 
healthy controls (HC) and trauma patients. Data are presented as area under the curve (AUC) 1051 
(A) or fold increase above vehicle treated controls (B). (C-D) Frequency (C) and absolute 1052 
number (D) of immature granulocytes (IG) in peripheral blood samples from healthy controls 1053 
(HC) and trauma patients. Number of samples analysed are shown below each time-point.
 1054 
*
p<0.01, 
**
p<0.001, 
***
p<0.0001 vs. HC.     1055 
 1056 
Figure 3. Traumatic injury results in impaired PMA-induced activation of p38 MAPK.               1057 
Phosphorylation status of P38 in resting and PMA-stimulated neutrophils isolated from 1058 
healthy controls (HC) and trauma patients 4-12 and 48-72 hours post-injury. Data are 1059 
presented as representative Western blots (B) and densitometry analysis of p38 1060 
phosphorylation in resting (A) or PMA-stimulated neutrophils at the 4-12H (C) and 48-72H 1061 
(D) post-injury time points. HC (n=7), 4-12h (n=9) and 48-72h (n=4). For (A) 
*
p<0.01, 1062 
**
p<0.001 vs. HC. For (C) and (D) 
**
p<0.001 vs. Time 0, 
#
p<0.01, 
###
p<0.0001 vs. HC 1063 
sample at matched time point.     1064 
 1065 
Figure 4. Traumatic injury results in impaired PMA-induced activation of ERK 1066 
MAPK. Phosphorylation status of ERK 1/2 in resting and PMA-stimulated neutrophils 1067 
isolated from healthy controls (HC) and trauma patients 4-12 and 48-72 hours post-injury. 1068 
Data are presented as representative Western blots (B) and densitometry analysis of ERK 1069 
phosphorylation in resting (A) or PMA-stimulated neutrophils at the 4-12h (C) and 48-72h 1070 
(D) post-injury time points. HC (n=4), 4-12h (n=8) and 48-72h (n=6). For (C) and (D) 1071 
*
p<0.01, 
**
p<0.001, 
***
p<0.0001 vs. Time 0, 
##
p<0.001, 
###
p<0.0001 vs. HC sample at 1072 
matched time point.     1073 
 1074 
Figure 5. Effect of traumatic injury on neutrophil glucose uptake and metabolism. 1075 
Glucose uptake by basal (A) or PMA-stimulated (B) neutrophils isolated from healthy 1076 
controls (HC) and trauma patients. MFI, Mean fluorescence intensity. (C-D) Comparison of 1077 
lactate concentration in cell-free supernatants collected from resting (C) or PMA stimulated 1078 
(D) neutrophils isolated from HC and trauma patients following a 3-hour in vitro culture. 1079 
Number of samples analysed are indicated below each time-point. 
* 
p<0.01, 
**
p<0.001, 1080 
***
p<0.0001 vs. HC. (E-F) Expression of the glycolytic enzymes pyruvate kinase (PKM2) 1081 
and lactate dehydrogenase A (LDHA) in resting neutrophils isolated from HC (n=5) and 1082 
trauma patients 48-72 hours post-injury (n=14). Data are presented as representative Western 1083 
blots (E) and densitometry analysis of collated data for LDHA (F, top panel) and PKM2                1084 
(F, bottom panel). 
*
p<0.01 vs. HC.   1085 
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Figure 6. Effect of mtDAMP pre-treatment on neutrophil NET generation. (A) Serum 1086 
concentrations of the mitochondrial-derived N-formylated peptide ND6 in peripheral blood 1087 
samples acquired from healthy controls (HC) and trauma patients. Number of samples 1088 
analysed are indicated below each time-point. 
***
p<0.0001 vs. HC. (B) NET production by 1089 
PMA stimulated neutrophils pre-treated with 40 or 100 µg/ml mtDAMPs was assessed by 1090 
measuring DNA content of cell-free supernatants (n=5). 
*
p<0.01 vs. Vehicle.  (C) MtDAMP-1091 
induced inhibition of NET generation was confirmed by fluorescence microscopy (n=5; top 1092 
panel x20 magnification; bottom panel x40 magnification). (D) ROS generation by 1093 
neutrophils pre-treated with 100 µg/ml mtDAMPs or vehicle control was measured in 1094 
response to stimulation with 25 nM PMA using luminol-based chemiluminescence (n=10). 1095 
Data are presented as area under the curve (AUC) and are mean±SEM. 
***
p<0.0001 vs. PMA.  1096 
 1097 
Figure 7. Treatment of neutrophils with mtDAMPs results in phosphorylation of 1098 
AMPK. (A) Whole cell lysates prepared from purified neutrophils stimulated for 2-15 1099 
minutes with 100 µg/ml mtDAMPs were screened for phosphorylated AMPK. Western blot 1100 
in top panel is representative of 4 independent experiments. For densitometry analysis 1101 
***
p<0.0001 vs. 0 minutes. (B) AMPK phosphorylation in neutrophils treated for 1-hour with 1102 
the FPR-1 antagonist Cyclosporin H (CsH) or (C) or the CaMKK inhibitor STO-609 prior to 1103 
a 5-minute stimulation with 100 µg/ml mtDAMPs. Blots are representative of 5 (B) and 10 1104 
(C) independent experiments, with densitometric data depicted in the accompanying 1105 
histogram. 
**
p<0.001, 
***
p<0.0001 vs. vehicle. (D) Comparison of PMA-induced NET 1106 
formation by mtDAMP stimulated neutrophils pre-treated with the AMPK inhibitor 1107 
compound C or vehicle control (n=10).  
**
p<0.01 vs. PMA treated. 1108 
 1109 
Figure 8. MtDAMP pre-treatment results in impaired neutrophil glycolysis.                              1110 
(A) Neutrophils pre-treated for 1-hour with 1 mM AICAR or vehicle control were stimulated 1111 
for 3 hours with 25 nM PMA, after which lactate concentrations were measured in cell-free 1112 
supernatants. Data are mean±SEM of 12 independent experiments. 
***
p<0.0001.                           1113 
(B) Comparison of lactate concentrations in supernatants collected from neutrophils pre-1114 
treated with 100 µg/ml mtDAMPs or vehicle-control and subsequently stimulated with 25 1115 
nM PMA for 1, 2 and 3 hours. Data are mean±SEM of 10 independent experiments. 1116 
**
p<0.001, 
***
p<0.0001 vs. vehicle. 1117 
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Table 1. Cohort demographics.  1136 
 1137 
 1138 
 
 
 Patients 
(n=62) 
 
Age, years 
Male, n (%) 
Time to pre-hospital sample, 
minutes post-injury 
 
ISS 
NISS 
 
 
AIS 
 
Head, n (%) 
Face, n (%) 
Chest, n (%) 
Abdomen, n (%) 
Spine, n (%) 
Pelvis, n (%) 
Limbs, n (%) 
Other, n (%) 
 
 
  
44 (19-95) 
56 (90) 
39 (13-59) 
 
 
26 (9-57) 
38 (9-75) 
 
 
 
 
24 (48) 
17 (34) 
29 (58) 
14 (28) 
19 (38) 
8 (16) 
28 (56) 
6 (12) 
Mechanism of injury  
                
Fall, n (%) 
A/P, n (%) 
Blunt, n (%)   
RTC, n (%) 
 
 
  
 
10 (16) 
13 (21) 
2 (3) 
37 (60) 
 
Outcomes 
 
ICU-free days 
Hospital-free days 
Mortality, n (%) 
  
 
22 (0-30) 
13 (0-29) 
8 (13) 
 
 1139 
Data are expressed as mean (range) unless indicated otherwise.  1140 
The number of data points for each clinical variable are: ISS and NISS, n=48; AIS scores, 1141 
n=50; ICU and hospital free days, n=53.  1142 
ICU-free days and hospital-free days were calculated by 30 minus the number of days the 1143 
patient stayed in hospital).  1144 
A/P, Assault/penetrating; AIS, Abbreviated injury scale; ISS, Injury severity score; ICU, 1145 
Intensive care unit; NISS, New injury severity score; RTC, Road traffic collision. 1146 
 1147 
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